Cargando…
地西他滨治疗骨髓增生异常综合征及相关肿瘤的疗效预测因素研究
OBJECTIVE: To identify clinical and molecular signatures for predicting response to decitabine (DAC) in patients with myelodysplastic syndrome (MDS) and related neoplasms. METHODS: The clinical characteristics of 109 patients with MDS and related neoplasms who were treated with DAC were analyzed ret...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354175/ https://www.ncbi.nlm.nih.gov/pubmed/28279036 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.02.008 |